Therapeutic proteins have been discovered and developed to treat intractable diseases, but many of them have not been put into practical use due to their high toxicity. However, the Company possesses technology of nanopolymeric micelles, an innovative drug delivery system that reacts to the body's pH and delivers drugs with pinpoint accuracy to affected areas. This technology enables the development of therapeutic drugs that are safer than ever before, while maintaining the efficacy of therapeutic proteins. Our goal is to bring medicines to patients with a variety of intractable diseases.